日本語 
Pharma
Curatis Holding AG has signed an exclusive licensing and development agreement with Japanese pharma company Neupharma for corticorelin, also known as C-PTBE-01. The research examines how to treat peritumoral brain…
Elix Provides AI Drug Discovery Platform “Elix DiscoveryTM” to KYORIN Pharmaceutical
Elix, Inc., a Japan-based AI drug discovery company, is pleased to announce…
Eisai’s Insomnia drug DAYVIGO approved for Use in China
Eisai Co., Ltd. DAYVIGO® (lemborexant) has been approved in China, where it’s…
PADCEV + KEYTRUDA improve Survival in Bladder Cancer
Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…
Nxera Launches Pipeline for Obesity, Weight Management
Nxera Pharma has launched a wide range of unique treatments. These aim…
Lantern Pharma completes LP-300 Lung cancer trial signup
Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted cancer therapies…
Protagenic Gets Japan Patent for Stilbenoid Drug Program
Protagenic Therapeutics, Inc. announces that on July 18, 2025, the Japanese Patent…
Infocom Launches DigiPro AI Compliance Tool for Pharma
Infocom Corporation has launched the DigiPro® AI Compliance Check Service , which…
MediciNova Shares Update on ALS, Triglyceride Trials
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and…
English